NEW & NOTABLE
View the latest issue of
CURE News
CURE and Yale OCR present the Yale BioHaven Entrepreneurship Series 2007-08. View
CURE releases 11th Annual Economic Report: Connecticut bioscience R&D spending up in biotechnology sector. View
WHY CONNECTICUT?
Connecticut's strategic location within the East Coast healthcare corridor is your competitive advantage.
Learn More
STEM CELL RESEARCH
Connecticut's stem cell law establishes state funding of $100 million for stem cell research.
The measure catapaults Connecticut into the vanguard of states that are taking active steps to encourage research in what many see as one of the most important avenues for bioscience investment.
Learn More
MULTIPLIER EFFECT
The effects of employment and spending by the state's bioscience industry are multiplied throughout the local economy.
Learn More